Dmitry Balyasny’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-9,428
Closed -$1.91M 2931
2022
Q4
$1.91M Hold
9,428
0.01% 1450
2022
Q3
$1.66M Buy
9,428
+7,100
+305% +$1.45M 0.01% 1582
2022
Q2
$469K Buy
+2,328
New +$496K ﹤0.01% 1997
2021
Q3
Sell
-133,860
Closed -$31.7M 2205
2021
Q2
$31.7M Buy
+133,860
New +$30.5M 0.15% 171
2015
Q1
Sell
-232,800
Closed -$21.6M 1016
2014
Q4
$21.6M Buy
+232,800
New +$20.6M 0.2% 149
2014
Q3
Sell
-232,800
Closed -$20.5M 796
2014
Q2
$20.5M Buy
+232,800
New +$20.2M 0.23% 94

Other funds holding LH

Dmitry Balyasny's LH Position: Q2 2026 in Review

Dmitry Balyasny reduced its Labcorp (LH) stake by 92% in Q2 2026, selling an estimated $5.43M and leaving 1,860 shares worth $521K. The position accounts for ﹤0.01% of the portfolio, ranked #2498.

Dmitry Balyasny first reported a position in LH in Q2 2013 and has held it in 32 quarters since. The position peaked at $133M in Q4 2014. 1,051 funds tracked by Wall St. Rank hold LH as of Q2 2026.

  • Dmitry Balyasny held 1,860 shares of Labcorp worth $521K as of Q2 2026.
  • Dmitry Balyasny sold 20,662 Labcorp shares in Q2 2026, an estimated $5.43M.
  • Labcorp made up ﹤0.01% of Dmitry Balyasny's portfolio in Q2 2026, its #2498 holding.
  • Dmitry Balyasny first reported a position in Labcorp in Q2 2013 and has held it in 32 quarters since.
  • Dmitry Balyasny's Labcorp position peaked at $133M in Q4 2014.
  • 1,051 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.

Based on Balyasny Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.